Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02542943 · ClinicalTrials.gov registry record · NA
Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity
A NA study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT02542943 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 240 participants.
The verdict
NCT02542943, a NA study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
This study will investigate the longitudinal efficacy of two experimental oral rinses containing 1.5% weight/weight (w/w) dipotassium oxalate monohydride (KOX), formulated at pH 4.5 and pH 7 respectively, for the relief of dentinal hypersensitivity (DH), compared to a placebo oral rinse, when used as an adjunct to twice daily brushing with a standard fluoride toothpaste.
Interventions
- DEVICE Experimental Oral Rinse 1
- DEVICE Experimental Oral Rinse 2
- OTHER Placebo Oral Rinse
- DRUG Standard fluoride toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2015-09 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02542943
The ClinicalTrials.gov registry entry for NCT02542943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Experimental Oral Rinse 1 is the first listed.
NCT02542943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02542943 about?
NCT02542943 is a clinical study titled "Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Dentinal Hypersensitivity". This study will investigate the longitudinal efficacy of two experimental oral rinses containing 1.5% weight/weight (w/w) dipotassium oxalate monohydride (KOX), formulated at pH 4.5 and pH 7 respectively, for the relief of dentinal hypersensitivity (DH), compared to a placebo oral rinse, when used a...
What is the current status of trial NCT02542943?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2015-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02542943?
The interventions under investigation include: Experimental Oral Rinse 1 (DEVICE), Experimental Oral Rinse 2 (DEVICE), Placebo Oral Rinse (OTHER), Standard fluoride toothpaste (DRUG).
Who is sponsoring clinical trial NCT02542943?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.